Skip Navigation

TAKEDA 201 - Bipolar I Depression

Principal Investigator: Jeffrey Rakofsky, MD

Summary: Testing the safety and efficacy of TAK-375 (Ramelteon) at 3 different doses or placebo for treatment of depressive episodes in Bipolar I Disorder.  (sublingual version of Rozerem, sleep medicine)

Contact:
Alison Oliver
Senior Researcher
404-727-8966
Alison.oliver@emory.edu